首页> 外文期刊>Science >ROS-Generating Mitochondrial DNA Mutations Can Regulate Tumor Cell Metastasis
【24h】

ROS-Generating Mitochondrial DNA Mutations Can Regulate Tumor Cell Metastasis

机译:ROS产生线粒体DNA突变可调节肿瘤细胞转移。

获取原文
获取原文并翻译 | 示例
获取外文期刊封面目录资料

摘要

Mutations in mitochondrial DNA (mtDNA) occur at high frequency in human tumors, but whether these mutations alter tumor cell behavior has been unclear. We used cytoplasmic hybrid (cybrid) technology to replace the endogenous mtDNA in a mouse tumor cell line that was poorly metastatic with mtDNA from a cell line that was highly metastatic, and vice versa. Using assays of metastasis in mice, we found that the recipient tumor cells acquired the metastatic potential of the transferred mtDNA. The mtDNA conferring high metastatic potential contained G13997A and 13885insC mutations in the gene encoding NADH (reduced form of nicotinamide adenine dinucleotide) dehydrogenase subunit 6 (ND6). These mutations produced a deficiency in respiratory complex I activity and were associated with overproduction of reactive oxygen species (ROS). Pretreatment of the highly metastatic tumor cells with ROS scavengers suppressed their metastatic potential in mice. These results indicate that mtDNA mutations can contribute to tumor progression by enhancing the metastatic potential of tumor cells.
机译:线粒体DNA(mtDNA)突变在人类肿瘤中的发生频率很高,但是这些突变是否会改变肿瘤细胞的行为尚不清楚。我们使用细胞质杂种(杂交)技术用高转移性细胞系中的mtDNA代替了转移性较差的小鼠肿瘤细胞系中的内源性mtDNA,反之亦然。使用小鼠中的转移测定,我们发现受体肿瘤细胞获得了转移的mtDNA的转移潜能。赋予高转移潜力的mtDNA在编码NADH(烟酰胺腺嘌呤二核苷酸的还原形式)脱氢酶亚基6(ND6)的基因中包含G13997A和13885insC突变。这些突变导致呼吸道复合物I活性不足,并与活性氧(ROS)的过量产生有关。用ROS清除剂预处理高度转移性肿瘤细胞可抑制其在小鼠中的转移潜力。这些结果表明,mtDNA突变可通过增强肿瘤细胞的转移潜能来促进肿瘤进展。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号